MP22-17 17-YEAR CAUSE-SPECIFIC SURVIVAL FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY
نویسندگان
چکیده
منابع مشابه
12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.
PURPOSE We reviewed the outcomes in men treated with permanent prostate brachytherapy (PPB). MATERIAL AND METHODS A total of 1,449 consecutive patients with a mean age of 68 years treated with PPB between 1992 and 2000 and mean pretreatment prostate specific antigen (PSA) 10.1 ng/ml were included in this study. Of the patients 55% presented with Gleason 6 tumors and 28% had Gleason 7 disease....
متن کاملImpact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
PURPOSE To review the impact of prior hormonal therapy on 10-year overall and prostate cancer specific survival after primary brachytherapy. METHODS AND MATERIALS A retrospective review was performed on the Arizona Oncology Services tumor registry for 2,378 consecutive permanent prostate brachytherapy cases from 1988 through 2001. Hormonal therapy was administered before the implant in 464 pa...
متن کاملFive year prostate-specific antigen outcomes after caesium prostate brachytherapy.
AIMS To report 5 year prostate-specific antigen outcomes in men undergoing prostate brachytherapy with caesium 131 at a single institution. MATERIALS AND METHODS All patients who underwent prostate brachytherapy with caesium 131 at our institution and had at least 24 months of follow-up were included in this study. The results are reported by risk group (low, intermediate and high) as well as...
متن کاملMetformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy
PURPOSE Several recent studies have suggested improved clinical outcomes in diabetic men with prostate cancer who also use metformin. We explore whether metformin use is associated with improved outcomes specifically in men undergoing prostate brachytherapy. MATERIAL AND METHODS 2,298 consecutive patients underwent permanent interstitial brachytherapy by a single brachytherapist (GSM). The co...
متن کاملSix-year experience of permanent prostate brachytherapy for clinically localized prostate cancer.
This report presents the outcome of prostate permanent brachytherapy (PPB). One hundred and seventy-two patients with clinically localized prostate cancer were treated with permanent brachytherapy using iodine-125 seeds (125-I) at Hiroshima University Hospital from July 2004 to June 2010. This study evaluated the efficacy of PPB in these patients. The median patient age was 69 years (range 53 t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Urology
سال: 2018
ISSN: 0022-5347,1527-3792
DOI: 10.1016/j.juro.2018.02.728